Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature Medicine 13, 1277 - 1278 (2007)
doi:10.1038/nm1107-1277
Reply to 'Microarrays: retracing steps'
Anil Potti1 & Joseph R Nevins1
- Duke Institute for Genome Sciences and Policy, Durham, North Carolina 27708, USA. e-mail: j.nevins@duke.edu
We appreciate the interest that Coombes et al.1 have shown in our reported results and agree that an algorithm that tracks the results of the various steps would be useful in such complex analyses. Unfortunately, they have not followed our methods in several crucial contexts and have made unjustified conclusions in others, and as a result their interpretation of our process is flawed.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Effects of the Dopamine D3 Receptor (DRD3) Gene Polymorphisms on Risperidone Response: A Pharmacogenetic StudyNeuropsychopharmacology Original Article
Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature Letters to Editor (19 Jan 2006)
An investigation of psychological, social and environmental correlates of obesity and weight gain in young womenInternational Journal of Obesity Original Article
Gene expression phenotypic models that predict the activity of oncogenic pathwaysNature Genetics Letter (01 Jun 2003)
Microarrays: retracing stepsNature Medicine Correspondence (01 Nov 2007)
